Literature DB >> 15450909

Microtubule-associated protein MAP2 expression in olfactory bulb in schizophrenia.

Lise Rioux1, Delta Ruscheinsky, Steven Edward Arnold.   

Abstract

Previous studies have described alterations in presynaptic and postsynaptic elements in various parts of the CNS in schizophrenia, which may, at least in part, be due to abnormalities in neurodevelopmental processes. The olfactory bulb (OB) is a unique CNS area for examining synaptic development and plasticity in schizophrenia because it undergoes continuous reinnervation throughout life. Moreover, olfactory deficits and reduced OB volume have been observed in schizophrenia. We investigated the expression in the OB of the microtubule-associated protein MAP2, which has been shown to be abnormally expressed in the hippocampal region in schizophrenia. In both developing and mature neurons, MAP2 is an important structural component of dendrites and participates in the modification of synaptic organization. We used immunocytochemistry with phosphoepitope-specific and phosphorylation-state-independent antibodies to examine MAP2 expression in the glomerular layer of the OB in elderly subjects with chronic schizophrenia and controls. Phosphorylation-independent MAP2 expression was significantly reduced in schizophrenia, while phosphorylated MAP2 expression did not differ between groups. These results are consistent with faulty OB innervation in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15450909     DOI: 10.1016/j.psychres.2004.05.022

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  9 in total

1.  Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia.

Authors:  Micah A Shelton; Jason T Newman; Hong Gu; Allan R Sampson; Kenneth N Fish; Matthew L MacDonald; Caitlin E Moyer; James V DiBitetto; Karl-Anton Dorph-Petersen; Peter Penzes; David A Lewis; Robert A Sweet
Journal:  Biol Psychiatry       Date:  2015-01-30       Impact factor: 13.382

2.  Density of small dendritic spines and microtubule-associated-protein-2 immunoreactivity in the primary auditory cortex of subjects with schizophrenia.

Authors:  Brandon C McKinney; Matthew L MacDonald; Jason T Newman; Micah A Shelton; Rebecca A DeGiosio; Ryan M Kelly; Kenneth N Fish; Allan R Sampson; David A Lewis; Robert A Sweet
Journal:  Neuropsychopharmacology       Date:  2019-02-22       Impact factor: 7.853

Review 3.  Dendritic spine alterations in schizophrenia.

Authors:  Caitlin E Moyer; Micah A Shelton; Robert A Sweet
Journal:  Neurosci Lett       Date:  2014-12-03       Impact factor: 3.046

4.  Deletion of the STOP gene, a microtubule stabilizing factor, leads only to discrete cerebral metabolic changes in mice.

Authors:  Ryosuke Hanaya; Estelle Koning; Arielle Ferrandon; Annie Schweitzer; Annie Andrieux; Astrid Nehlig
Journal:  J Neurosci Res       Date:  2008-03       Impact factor: 4.164

5.  Increased stability of microtubules in cultured olfactory neuroepithelial cells from individuals with schizophrenia.

Authors:  Alan S Brown; Karin Borgmann-Winter; Chang-Gyu Hahn; Lorna Role; David Talmage; Raquel Gur; Jacky Chow; Patric Prado; Thelma McCloskey; Yuanyuan Bao; J Chloe Bulinski; Andrew J Dwork
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-10-24       Impact factor: 5.067

6.  Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia.

Authors:  Chijioke N Egbujo; Duncan Sinclair; Karin E Borgmann-Winter; Steven E Arnold; Bruce I Turetsky; Chang-Gyu Hahn
Journal:  Schizophr Res       Date:  2015-08-07       Impact factor: 4.939

7.  MAP2 immunoreactivity deficit is conserved across the cerebral cortex within individuals with schizophrenia.

Authors:  Rebecca DeGiosio; Ryan M Kelly; Adam M DeDionisio; Jason T Newman; Kenneth N Fish; Allan R Sampson; David A Lewis; Robert A Sweet
Journal:  NPJ Schizophr       Date:  2019-08-28

8.  More than a marker: potential pathogenic functions of MAP2.

Authors:  Rebecca A DeGiosio; Melanie J Grubisha; Matthew L MacDonald; Brandon C McKinney; Carlos J Camacho; Robert A Sweet
Journal:  Front Mol Neurosci       Date:  2022-09-16       Impact factor: 6.261

9.  MAP2 is differentially phosphorylated in schizophrenia, altering its function.

Authors:  M J Grubisha; X Sun; M L MacDonald; M Garver; Z Sun; K A Paris; D S Patel; R A DeGiosio; D A Lewis; N A Yates; C Camacho; G E Homanics; Y Ding; R A Sweet
Journal:  Mol Psychiatry       Date:  2021-02-01       Impact factor: 15.992

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.